PAX8 and thyroid cancer: Meanwhile, PAX8-AS1 overexpression is related to the poor recurrence-free survival (RFS) in UCEC [26] and thyroid cancer [44], suggesting that PAX8-AS1 contributes to disease recurrence in these cancers.